Special Issue "Innovations and Technical Advances in Cardiothoracic Surgery"

Dear Colleagues,

The increasing pace of advances in cardiothoracic surgery in recent decades has fundamentally altered the natural course of treatment of patients with heart and lung disease. The advancements have focused on reducing the need for invasive surgery, reducing pain and hospital stay, and improving outcomes for a faster recovery and return to regular life. In recent years, available therapies have been revolutionized completely by new robotic, thoracoscopic and transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Furthermore, molecular biology and genetics have had a rapidly growing impact on cardiothoracic diseases, allowing the field of regenerative medicine and thoracic oncology to grow closer to routine clinical implementation.

This Special Issue of the Journal of Clinical Medicine is dedicated to advances in the management of heart failure, valvular disorders, myocardial ischemia, and arrhythmias. The issue also focuses on advances in the management of thoracic disease, including lung and esophageal disease, as well as molecular and genetic advancements in the treatment of thoracic oncology. The articles may focus on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations not yet been in clinical scenarios. Additionally, discussions on future challenges and opportunities for clinical implementation are welcome. This issue aims to provide information to physicians who want to stay up to date with current therapies and those interested in the future of cardiothoracic disease, biomedical companies seeking innovation opportunities, and those wishing to broaden their knowledge of new cardiothoracic therapeutic options.

Dr. Irbaz Hameed
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiothoracic surgery
• coronary artery bypass grafting
• cardiovascular interventions
• cardiac mri
• heart failure
• valvular disorders
• myocardial ischemia
• arrhythmias